Doyle Anthony 4/A
4/A · BIOCRYST PHARMACEUTICALS INC · Filed Jan 13, 2022
Insider Transaction Report
Form 4/AAmended
Doyle Anthony
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-14+75,000→ 168,719 total
Footnotes (1)
- [F1]The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date.